MYONAL should only be used in pregnant women or women suspected of being pregnant, if the expected therapeutic benefits are evaluated to outweigh the possible risk of treatment. [The safety of MYONAL in pregnant women
has not been established.]
It is advisable to avoid the administration of MYONAL to nursing mothers. When MYONAL must be used, breastfeeding should be discontinued during treatment. [It has been reported that Myonal is excreted in breast milk in an animal study (in rats).]
Sign Out